Diagnostic Medical Systems SA Total Assets
Diagnostic Medical Systems SA total assets. Based on the latest financial reports, Diagnostic Medical Systems SA (ALDMS) holds total assets worth €62.52 Million EUR (≈ $73.09 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Diagnostic Medical Systems SA (ALDMS) total market value for the company's overall valuation and market capitalisation.
Total Assets of Diagnostic Medical Systems SA (2009–2025)
Total assets of Diagnostic Medical Systems SA from 2009 to 2025. This chart illustrates how Diagnostic Medical Systems SA's total assets have evolved over time, based on quarterly financial data. See latest Diagnostic Medical Systems SA stock price today for real-time trading data and today's change.
Diagnostic Medical Systems SA - Asset Composition Analysis
Diagnostic Medical Systems SA Total Assets Breakdown (December 2025)
Diagnostic Medical Systems SA total assets breakdown as of December 2025. Diagnostic Medical Systems SA's total assets of €62.52 Million consist of 60.7% current assets and 39.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 11.4% |
| Accounts Receivable | €13.09 Million | 20.9% |
| Inventory | €15.68 Million | 25.1% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €12.10 Million | 19.4% |
| Goodwill | €8.02 Million | 12.8% |
Asset Composition Trend (2009–2025)
This chart illustrates how Diagnostic Medical Systems SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ALDMS net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Diagnostic Medical Systems SA's current assets represent 60.7% of total assets in 2025, a decrease from 85.7% in 2009.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2025, down from 11.5% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, an increase from 10.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 25.1% of total assets.
Diagnostic Medical Systems SA Competitors by Total Assets
Key competitors of Diagnostic Medical Systems SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
Paxman AB
ST:PAX
|
Sweden | Skr487.65 Million |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Pulsenmore Ltd
TA:PULS
|
Israel | ILA120.34 Million |
Diagnostic Medical Systems SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.37 | 1.29 | 1.35 |
| Quick Ratio | 0.81 | 0.67 | 0.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €10.33 Million | €6.80 Million | €6.35 Million |
Diagnostic Medical Systems SA - Advanced Valuation Insights
This section examines the relationship between Diagnostic Medical Systems SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 15.9% |
| Total Assets | €62.52 Million |
| Market Capitalization | $27.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values Diagnostic Medical Systems SA's assets below their book value (0.44x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Diagnostic Medical Systems SA's assets grew by 15.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Diagnostic Medical Systems SA (2009–2025)
The table below shows the annual total assets of Diagnostic Medical Systems SA from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €62.52 Million ≈ $73.09 Million |
+15.88% |
| 2024-12-31 | €53.95 Million ≈ $63.07 Million |
+5.50% |
| 2023-12-31 | €51.14 Million ≈ $59.79 Million |
-5.11% |
| 2022-12-31 | €53.89 Million ≈ $63.01 Million |
+1.63% |
| 2021-12-31 | €53.03 Million ≈ $62.00 Million |
+15.79% |
| 2020-12-31 | €45.80 Million ≈ $53.54 Million |
+13.68% |
| 2019-12-31 | €40.28 Million ≈ $47.10 Million |
+9.35% |
| 2018-12-31 | €36.84 Million ≈ $43.07 Million |
-8.09% |
| 2017-12-31 | €40.08 Million ≈ $46.86 Million |
-19.81% |
| 2016-12-31 | €49.98 Million ≈ $58.43 Million |
+7.66% |
| 2015-12-31 | €46.42 Million ≈ $54.27 Million |
+17.84% |
| 2014-12-31 | €39.40 Million ≈ $46.06 Million |
+67.16% |
| 2013-12-31 | €23.57 Million ≈ $27.55 Million |
+1.77% |
| 2012-12-31 | €23.16 Million ≈ $27.07 Million |
+9.90% |
| 2011-12-31 | €21.07 Million ≈ $24.63 Million |
-2.59% |
| 2010-12-31 | €21.63 Million ≈ $25.29 Million |
+8.53% |
| 2009-12-31 | €19.93 Million ≈ $23.30 Million |
-- |
About Diagnostic Medical Systems SA
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.